Related Experiment Video

Updated: Jan 6, 2026

A Protocol for Explant Cultures of IDH1-mutant Diffuse Low-grade Gliomas
06:27

A Protocol for Explant Cultures of IDH1-mutant Diffuse Low-grade Gliomas

Published on: May 9, 2025

1.1K

Clinical and molecular characteristics and prognostic factors of diffuse astrocytoma, IDH-wildtype, not elsewhere

Woo Jong Cho1, Kaeum Choi2, Kyunghwa Han1

  • 1Department of Radiology and Research Institute of Radiological Science and Center for Clinical Imaging Data Science, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul, 03722, Korea.

Journal of Neuro-Oncology
|December 1, 2025
PubMed
Abstract

No abstract available in PubMed .

Keywords:
GliomaMagnetic resonance imagingNot elsewhere classifiedSurvivalWorld Health Organization

More Related Videos

Digital Spatial Profiling for Characterization of the Microenvironment in Adult-Type Diffusely Infiltrating Glioma
09:17

Digital Spatial Profiling for Characterization of the Microenvironment in Adult-Type Diffusely Infiltrating Glioma

Published on: September 13, 2022

2.7K
A Protocol for Rapid Post-mortem Cell Culture of Diffuse Intrinsic Pontine Glioma DIPG
08:46

A Protocol for Rapid Post-mortem Cell Culture of Diffuse Intrinsic Pontine Glioma DIPG

Published on: March 7, 2017

17.4K

Related Experiment Videos

Last Updated: Jan 6, 2026

A Protocol for Explant Cultures of IDH1-mutant Diffuse Low-grade Gliomas
06:27

A Protocol for Explant Cultures of IDH1-mutant Diffuse Low-grade Gliomas

Published on: May 9, 2025

1.1K
Digital Spatial Profiling for Characterization of the Microenvironment in Adult-Type Diffusely Infiltrating Glioma
09:17

Digital Spatial Profiling for Characterization of the Microenvironment in Adult-Type Diffusely Infiltrating Glioma

Published on: September 13, 2022

2.7K
A Protocol for Rapid Post-mortem Cell Culture of Diffuse Intrinsic Pontine Glioma DIPG
08:46

A Protocol for Rapid Post-mortem Cell Culture of Diffuse Intrinsic Pontine Glioma DIPG

Published on: March 7, 2017

17.4K

Related Concept Videos

Tumor Progression02:07

Tumor Progression

7.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K

Articles linked to this work by shared authors, journal, and citation graph.

Impact of aggressive treatment on outcomes in IDH-wildtype glioblastoma patients with leptomeningeal dissemination.

International journal of radiation oncology, biology, physics·2026

Two-Decade Trends in Radiotherapy Patterns and Clinical Outcomes for Soft Tissue Sarcoma: A Nationwide Study in South Korea (2005-2023).

Cancer medicine·2026

Simpson Grading and Risk of Recurrence in 4074 Meningioma Patients With Gross Total Resection.

Neurosurgery·2026

Increased risk of early recurrence after gross-total resection in males with a WHO grade II meningioma: the impact of sex on recurrence and death in 5441 meningioma patients.

Journal of neurosurgery·2026

Reduced-dose Radiotherapy without Chemotherapy for Intracranial Germinomas: Results from an Asian Multicenter Study.

Neuro-oncology·2026

Variation in meningioma recurrence risk estimates across observational cohorts: the influence of calendar time, WHO classifications, geographical settings, and healthcare systems.

Journal of neuro-oncology·2026

Radiological features of peritumoral brain injury and neurological outcomes after glioma surgery: a prospective observational study.

Journal of neuro-oncology·2026

Weekly hippocampal diffusion changes during partial-brain radiation therapy for high-grade glioma: associations with dose and early memory change.

Journal of neuro-oncology·2026

Monocytic resilience during chemoradiotherapy is independently associated with survival in IDH-Wildtype glioblastoma.

Journal of neuro-oncology·2026

MGMT promoter methylation as a molecular biomarker in neuro-oncology: current practices, challenges, and future directions.

Journal of neuro-oncology·2026

Leveraging traditional and advanced machine learning for comprehensive oncology data integration and outcome prediction.

Journal of neuro-oncology·2026

Comparative dosing of bevacizumab for radiation necrosis: impact of tumor type on edema response.

Journal of neuro-oncology·2026

Identification of the Novel HLA-C*07:997 Allele Using Third-Generation HLA-Targeted Sequencing Technology.

HLA·2026

Case Report: Fabry cardiomyopathy associated with a novel truncating GLA variant, c.837_838delinsAT, p.(Gln280Ter).

Frontiers in medicine·2026

Three-Way Chromosomal Translocation Involving KMT2A::MLLT3 in AML: A Case Report and Genomic Characterization.

Cytogenetic and genome research·2026

Identification of the Novel HLA-G*01:01:39 Allele Using PolyseqOne Sequencing.

HLA·2026

Identification and Characterisation of a Novel HLA-DPB1*1985:01 Allele by Long-Read Sequencing.

HLA·2026

Splenomegaly With Thrombocytopenia: A Case of the Rare and Obvious.

Journal of pediatric hematology/oncology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us